Anlotinib Hydrochloride
FocusV(Anlotinib
- Medicine Name: Focus V
- API: Anlotinib Hydrochloride
- Dosage Form & Strength: Capsules: 12 mg
- Manufactured By: Sino Biopharm Ltd
Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor used for the treatment of advanced NSCLC, soft1s tissue sarcomas, small cell lung cancer, advanced or metastatic medullary thyroid cancer (MTC), and differentiated thyroid cancer (DTC).
Recommended Dosage: The recommended dosage of Anlotinib hydrochloride can vary depending on the specific type of cancer being treated and individual patient factors. Anlotinib Hydrochloride capsules are usually taken orally with water. Swallow the capsules whole; do not crush or open them unless instructed otherwise by your healthcare provider. Take the capsules with or without food, depending on your healthcare provider’s instructions.
- Anlotinib may impact cardiovascular function. Regular monitoring of blood pressure and cardiac function is crucial, especially for individuals with a history of cardiovascular disease.
- Anlotinib 12 mg increases the risk of bleeding. Caution is advised for patients prone to bleeding disorders, and prompt medical attention is necessary for any signs of bleeding, such as unusual bruising or blood in stools.
- Elevated blood pressure is a common side effect. Adequate blood pressure control measures, including medications if necessary, should be employed to manage hypertension during Anlotinib treatment.
- Thyroid dysfunction, particularly hypothyroidism, may occur. Thyroid function should be regularly assessed, and thyroid hormone replacement therapy may be necessary.
- Anlotinib can lead to proteinuria. Regular urine protein testing is advised, and appropriate management strategies should be implemented if significant proteinuria is detected.
- Anlotinib has potential risks to the fetus. Pregnancy should be avoided during treatment, and effective contraception is essential. Breastfeeding is contraindicated due to potential adverse effects on the infant.
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
- A valid prescription from Doctor
- Import permit if applicable
- On availability Anlotinib in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.